期刊文献+

氢化物-原子吸收光谱法测定人凝血酶原复合物中锑的含量

Determination of antimony in human prothrombin complex by hydride generation-atomic absorption spectrometry
暂未订购
导出
摘要 目的建立人凝血酶原复合物中锑含量的测定方法。方法使用氢化物-原子吸收光谱法测定人凝血酶原复合物中锑的含量。结果锑含量在0-25.0 ng/ml范围内呈良好的线性关系,相关系数大于0.99;检出限为0.5533 ng/ml,定量限为1.844 ng/ml;加样回收率为95.93%-118.62%。结论本研究所建立方法简单、快速、灵敏度高,可用于测定人凝血酶原复合物锑的含量。 Objective To establish a method for the determination of antimony content in human prothrombin complex.Methods The content of antimony in human prothrombin complex was determined by hydride generation-atomic absorption spectrometry.Results The calibration curve of antimony was linear in the range of 0-25.0 ng/ml with correlation coefficient higher than 0.99.The detection limit was 0.5533 ng/ml and the quantitative limit was 1.844 ng/ml.The recoveries were 95.93%-118.62%.Conclusion The method is simple,rapid,accurate and sensitive,and can be suitable for the determination of antimony in human prothrombin complex.
作者 吴勰乾 韩杨 霍建富 连建科 任飞 WU Xieqian;HAN Yang;HUO Jianfu;LIAN Jianke;REN Fei(Department of Technical Centre,Shanxi Kangbao Biological Product CO.,Ltd,Changzhi 046000,China;Central Laboratory,Changzhi Medical College)
出处 《山西医科大学学报》 CAS 2020年第7期674-677,共4页 Journal of Shanxi Medical University
基金 长治医学院博士科研启动基金资助项目(BS1703) 山西省教育厅高校科技创新计划项目(2019L0684)。
关键词 人凝血酶原复合物 氢化物-原子吸收光谱法 human prothrombin complex antimony hydride generation-atomic absorption spectrometry
  • 相关文献

参考文献4

二级参考文献68

  • 1黄丽春,石重光,陈家玉.三氧化二锑小鼠急性毒性实验研究[J].职业卫生与病伤,1996,11(3):170-171. 被引量:7
  • 2Surgenor DM, Melin M, Steele BB, et al. Preparation of barium sulphate eluate of plasma for physiological studies in humans[ J]. Vox Sang ,1959, 4( 1 ) : 71-72
  • 3Barrowcliffe TW, Stableforth P, Dormandy KM. Small scale preparation and clinical use of factor IX prothrombin complex[ J]. Vox Sang,1973, 25(5) : 426-441
  • 4Hoag MS, Johnson FF, Robinson JA, et al. Treatment of hemophilia B with a new clotting -factor concentrate [ j ]. New Engl J Med,1969, 280(11 ): 581-586
  • 5Tharakan JP, Dan M Gee, David B Clark, ct al. A semi-continuous method for purification of factor complex from human plasma[ J ]. Vox Sang, 1989, 57(4) : 233-239
  • 6Heystek J, Brummelhuis HGJ, Krijnen HW. Contributions to the opitimal use of human blood. Ⅱ. The large-scale preparation of prothrombin complex, a comparison between two methods using the anion exchangers DEAE-Cellulose DE 52 and DEAE-Sephadex A- 50[J]. Vox Sang,1973, 25(2) : 113-123
  • 7Human prothrombm Complex. European Pharmacopoeia[S]. 6th Evropean Directorate for the Quality of Medicines. 2007
  • 8人凝血酶原复合物.中华人民共和国药典第三部[S].北京:化学工业出版社.2005
  • 9Ruiz-Sdea A, Hong A, Arguello A, ct al. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate [ J]. Haemophilia,2005,11 ( 6 ) : 583-588
  • 10Ostermann H, Haertel S, Knaub S, et al. Pharmaeokineties of Beriplex P/N prothrombin complex coneertrate in healthy volunteers [ J ]. Thromb Haemost ,2007, 98 ( 4 ) :790-797

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部